(VIANEWS) – Shares of 10x Genomics (NASDAQ: TXG) jumped by a staggering 26.99% in 14 days from $39.5 to $50.16 at 15:35 EST on Tuesday, after three successive sessions in a row of losses. NASDAQ is falling 0.3% to $11,354.62, following the last session’s upward trend.

10x Genomics’s last close was $49.76, 76.19% under its 52-week high of $208.99.


Today’s last reported volume for 10x Genomics is 1600119 which is 16.85% above its average volume of 1369273.

10x Genomics’s Sales

10x Genomics’s sales growth is 78.1% for the ongoing quarter and 33.2% for the next. The company’s growth estimates for the ongoing quarter and the next is 70.8% and 97.2%, respectively.

10x Genomics’s Revenue

Year-on-year quarterly revenue growth grew by 170%, now sitting on 405.7M for the twelve trailing months.


10x Genomics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.76%, a negative 0.54%, and a positive 4.79%, respectively.

10x Genomics’s highest amplitude of average volatility was 3.74% (last week), 5.11% (last month), and 4.79% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

10x Genomics’s stock is considered to be oversold (<=20).

10x Genomics’s Stock Yearly Top and Bottom Value

10x Genomics’s stock is valued at $50.16 at 15:35 EST, way below its 52-week low of $128.15.

10x Genomics’s Moving Average

10x Genomics’s worth is way below its 50-day moving average of $155.93 and way below its 200-day moving average of $170.12.

More news about 10x Genomics (TXG).


Please enter your comment!
Please enter your name here